OTCPK:HOCP.Y

Stock Analysis Report

Executive Summary

HOYA Corporation engages in the life care and information technology businesses.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has HOYA's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.3%

OTCPK:HOCP.Y

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

40.2%

OTCPK:HOCP.Y

9.9%

US Medical Equipment

1.6%

US Market

HOCP.Y outperformed the Medical Equipment industry which returned 9.9% over the past year.

HOCP.Y outperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

HOCP.YIndustryMarket
7 Day2.3%0.5%-0.02%
30 Day4.1%0.09%2.7%
90 Day11.4%2.0%1.4%
1 Year40.2%40.2%10.8%9.9%3.8%1.6%
3 Year100.9%100.9%69.0%63.9%45.2%35.8%
5 Year146.2%146.2%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is HOYA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is HOYA undervalued based on future cash flows and its price relative to the stock market?

27.18x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

HOYA's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

HOYA's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

HOYA is good value based on earnings compared to the US Medical Equipment industry average.

HOYA is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

HOYA is poor value based on expected growth next year.


Price Based on Value of Assets

HOYA is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is HOYA expected to perform in the next 1 to 3 years based on estimates from 13 analysts?

6.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

HOYA's revenue is expected to grow by 4.9% yearly, however this is not considered high growth (20% yearly).

HOYA's earnings are expected to grow by 6.7% yearly, however this is not considered high growth (20% yearly).

HOYA's revenue growth is positive but not above the United States of America market average.

HOYA's earnings growth is positive but not above the United States of America market average.

HOYA's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

HOYA is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has HOYA performed over the past 5 years?

7.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

HOYA's year on year earnings growth rate has been positive over the past 5 years.

HOYA's 1-year earnings growth exceeds its 5-year average (20.2% vs 7.5%)

HOYA's earnings growth has not exceeded the US Medical Equipment industry average in the past year (20.2% vs 28.2%).


Return on Equity

HOYA has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).


Return on Assets

HOYA used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

HOYA has improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is HOYA's financial position?


Financial Position Analysis

HOYA is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

HOYA's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

HOYA's level of debt (3.7%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (12.1% vs 3.7% today).

Debt is well covered by operating cash flow (694.9%, greater than 20% of total debt).

HOYA earns more interest than it pays, coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 21.6x debt.


Next Steps

Dividend

What is HOYA's current dividend yield, its reliability and sustainability?

1.18%

Expected Dividend Yield


Dividend Yield and Payments Analysis

HOYA's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

HOYA's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (3.6x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of HOYA's salary, the management and board of directors tenure and is there insider trading?

4.7yrs

Average board tenure


CEO

Hiroshi Suzuki (61yo)

16.3yrs

Tenure

JP¥172,000,000

Compensation

Mr. Hiroshi Suzuki has been the Chief Executive Officer of Hoya Corp. since June 2003 and has been its President since June 2000. Mr. Suzuki serves as Representative Executive Officer at Hoya Corp. He serv ...


CEO Compensation Analysis

Hiroshi's remuneration is lower than average for companies of similar size in United States of America.

Hiroshi's compensation has been consistent with company performance over the past year, both up more than 20%.


Board Age and Tenure

4.7yrs

Average Tenure

71yo

Average Age

The tenure for the HOYA board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Augustine Yee (51yo)

    Executive Officer

    • Tenure: 5.3yrs
    • Compensation: JP¥107.00m
  • Hiroshi Suzuki (61yo)

    Representative Executive Officer

    • Tenure: 16.3yrs
    • Compensation: JP¥172.00m
  • Ryo Hirooka (45yo)

    Representative Executive Officer & CFO

    • Tenure: 0yrs
    • Compensation: JP¥138.00m
  • Eiichiro Ikeda (49yo)

    Executive Officer

    • Tenure: 0yrs
    • Compensation: JP¥105.00m

Board Members

  • Takeo Takasu (74yo)

    Outside Director

    • Tenure: 5.3yrs
  • Shuzo Kaihori (71yo)

    Independent Director

    • Tenure: 4.2yrs
  • Hiroshi Suzuki (61yo)

    Representative Executive Officer

    • Tenure: 16.3yrs
    • Compensation: JP¥172.00m
  • Mitsudo Urano (71yo)

    Lead Independent Director

    • Tenure: 0.7yrs
  • Yukako Uchinaga (73yo)

    Outside Director

    • Tenure: 6.3yrs
  • Hiro Yoshihara (62yo)

    Independent Director

    • Tenure: 1.3yrs

Company Information

HOYA Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: HOYA Corporation
  • Ticker: HOCP.Y
  • Exchange: OTCPK
  • Founded: 1941
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: JP¥3.336t
  • Listing Market Cap: JP¥30.882b
  • Shares outstanding: 376.97m
  • Website: https://www.hoya.co.jp

Number of Employees


Location

  • HOYA Corporation
  • Nittochi Nishishinjuku Building
  • 20th Floor
  • Tokyo
  • 160-8347
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HOCP.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 1992
HYBDB (Deutsche Boerse AG)YesCommon StockDEEURJan 1992
7741TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYJan 1992
HOCP.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDSep 2004

Biography

HOYA Corporation engages in the life care and information technology businesses. The company offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endosco ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 23:50
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.